• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[甲状腺毒症性周期性瘫痪发病机制研究的最新进展]

[Recent progress on the searchs of pathogenesis of thyrotoxic periodic paralysis].

作者信息

Shishiba Yoshiaki

机构信息

Kimitsu Hospital.

出版信息

Nihon Rinsho. 2006 Dec;64(12):2339-47.

PMID:17154102
Abstract

In Japan, more than 60% of hypokalemic periodic paralysis is thyrotoxic instead of familial type frequently experienced in Caucasian countries. The pathogenesis of familial hypokalemic periodic paralysis (FHPP) has been elucidated to be due to the mutation of one of the genes in either Ca(CACN1AS), Na(SCN4A) or K channel(KCNE3). Clinical features of thyrotoxic periodic paralysis (TPP) is very similar to that of FHPP and rigorous attempts have been devoted to the search of the gene mutation of ion channels in TPP. To date, however, no such an attempt has been successful except for the findings of SNiPs in those ion channel genes or in the vicinity of TRE of CACN1AS. Those SNiPs may provide a risk to the attack of TPP. In TPP, we and others reported that the serum insulin level tremendously elevated prior to the attack of paralysis. There were clinical evidences indicating that hypokalemic periodic paralysis is caused by the depolarization block of muscle cell membrane instead of hyperpolarization block once assumed previously. Otsuka reported that insulin can induce depolarization block of muscle membrane in low K concentration by increasing membrane permeability to Na. We have reported that K deficiency and thyroid hormone excess increased NaK-ATPase and may sensitize the muscle membrane to the effect of insulin to cause depolarization in an animal model. In fact, in Japan, incidence of TPP of male decreased from 8.6% in 1958 to 4.3% in 1998. During this 40 years, intake of K was increased from 43 to 65 mEq per day per person as described by the National Survey of Nutrition. The SNiPs of ion channel genes, together with K deficiency or thyroid hormone excess, may provide a risk to the occurrence of TPP.

摘要

在日本,超过60%的低钾性周期性麻痹是甲状腺毒症性的,而非白种人国家常见的家族性类型。家族性低钾性周期性麻痹(FHPP)的发病机制已被阐明是由于钙(CACN1AS)、钠(SCN4A)或钾通道(KCNE3)中某一基因的突变。甲状腺毒症性周期性麻痹(TPP)的临床特征与FHPP非常相似,人们一直致力于寻找TPP中离子通道的基因突变。然而,迄今为止,除了在那些离子通道基因或CACN1AS的TRE附近发现单核苷酸多态性(SNiPs)外,此类尝试均未成功。这些SNiPs可能会增加TPP发作的风险。在TPP中,我们和其他人报告称,在麻痹发作前血清胰岛素水平会大幅升高。有临床证据表明,低钾性周期性麻痹是由肌肉细胞膜的去极化阻滞引起的,而非先前认为的超极化阻滞。大冢报告称,胰岛素可通过增加细胞膜对钠的通透性,在低钾浓度下诱导肌肉膜的去极化阻滞。我们报告称,钾缺乏和甲状腺激素过多会增加钠钾-ATP酶活性,并可能使肌肉膜对胰岛素的作用更加敏感,从而在动物模型中导致去极化。事实上,在日本,男性TPP的发病率从1958年的8.6%降至1998年的4.3%。根据全国营养调查,在这40年中,人均每日钾摄入量从43增加到了65毫当量。离子通道基因的SNiPs,连同钾缺乏或甲状腺激素过多,可能会增加TPP发生的风险。

相似文献

1
[Recent progress on the searchs of pathogenesis of thyrotoxic periodic paralysis].[甲状腺毒症性周期性瘫痪发病机制研究的最新进展]
Nihon Rinsho. 2006 Dec;64(12):2339-47.
2
[Current status of clinical and molecular-biological research on familial periodic paralysis].[家族性周期性麻痹的临床及分子生物学研究现状]
Nihon Rinsho. 1997 Dec;55(12):3239-46.
3
Clinical review: Thyrotoxic periodic paralysis: a diagnostic challenge.临床综述:甲状腺毒症性周期性瘫痪:一项诊断挑战。
J Clin Endocrinol Metab. 2006 Jul;91(7):2490-5. doi: 10.1210/jc.2006-0356. Epub 2006 Apr 11.
4
Absence of ion channels CACN1AS and SCN4A mutations in thyrotoxic hypokalemic periodic paralysis.甲状腺毒症性低钾性周期性麻痹中离子通道CACN1AS和SCN4A突变的缺失。
Thyroid. 2004 Mar;14(3):187-90. doi: 10.1089/105072504773297858.
5
A mutation in the KCNE3 potassium channel gene is associated with susceptibility to thyrotoxic hypokalemic periodic paralysis.KCNE3钾通道基因的突变与甲状腺毒症性低钾性周期性麻痹的易感性相关。
J Clin Endocrinol Metab. 2002 Nov;87(11):4881-4. doi: 10.1210/jc.2002-020698.
6
Periodic paralysis and the sodium-potassium pump.周期性麻痹与钠钾泵
Ann Neurol. 1982 Jun;11(6):547-52. doi: 10.1002/ana.410110602.
7
Analytic review: thyrotoxic periodic paralysis: a review.分析性综述:甲状腺毒症性周期性瘫痪:综述。
J Intensive Care Med. 2010 Mar-Apr;25(2):71-7. doi: 10.1177/0885066609358849. Epub 2010 Jan 19.
8
INa and IKir are reduced in Type 1 hypokalemic and thyrotoxic periodic paralysis.ⅠNa 和ⅠKir 在 1 型低钾性和甲状腺毒性周期性瘫痪中减少。
Muscle Nerve. 2010 Sep;42(3):315-27. doi: 10.1002/mus.21693.
9
Thyrotoxic periodic paralysis in an Italian man: clinical manifestation and genetic analysis.一名意大利男子的甲状腺毒症性周期性瘫痪:临床表现与基因分析。
Ann Clin Biochem. 2008 Mar;45(Pt 2):218-20. doi: 10.1258/acb.2007.007117.
10
Mutation screening in Chinese hypokalemic periodic paralysis patients.中国低钾性周期性麻痹患者的基因突变筛查
Mol Genet Metab. 2006 Apr;87(4):359-63. doi: 10.1016/j.ymgme.2005.10.020. Epub 2006 Jan 4.

引用本文的文献

1
Chest pain and paralysis after pulse prednisolone therapy an unusual case presentation of thyrotoxic periodic paralysis: a case report.脉冲式泼尼松龙治疗后出现胸痛和麻痹:甲状腺毒症性周期性麻痹的罕见病例报告
Cases J. 2009 Aug 25;2:7501. doi: 10.4076/1757-1626-2-7501.